CVE-2023-47533 — MEDIUM (5.9)

Q: What is CVE-2023-47533?

CVE-2023-47533 is a vulnerability with a CVSS score of 5.9 (MEDIUM). Auth. (admin+) Stored Cross-Site Scripting (XSS) vulnerability in wpdevart Countdown and CountUp, WooCommerce Sales Timer plugin <= 1.8.2 versions.

Q: How severe is CVE-2023-47533?

CVE-2023-47533 has been rated MEDIUM with a CVSS base score of 5.9/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2023-47533?

Check the references section above for vendor advisories and patch information. Affected products include: Wpdevart Countdown And Countup\, Woocommerce Sales Timer.

Vulnerability Description

Auth. (admin+) Stored Cross-Site Scripting (XSS) vulnerability in wpdevart Countdown and CountUp, WooCommerce Sales Timer plugin <= 1.8.2 versions.

CVSS Score

5.9

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:L/I:L/A:L

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

HIGH

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

LOW

Affected Products

Vendor	Product	Versions
Wpdevart	Countdown And Countup\, Woocommerce Sales Timer	<= 1.8.2

Related Weaknesses (CWE)

CWE-79

References

https://patchstack.com/database/vulnerability/countdown-wpdevart-extended/wordprThird Party Advisory
https://patchstack.com/database/vulnerability/countdown-wpdevart-extended/wordprThird Party Advisory

FAQ

What is CVE-2023-47533?

CVE-2023-47533 is a vulnerability with a CVSS score of 5.9 (MEDIUM). Auth. (admin+) Stored Cross-Site Scripting (XSS) vulnerability in wpdevart Countdown and CountUp, WooCommerce Sales Timer plugin <= 1.8.2 versions.

How severe is CVE-2023-47533?

CVE-2023-47533 has been rated MEDIUM with a CVSS base score of 5.9/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-47533?

Check the references section above for vendor advisories and patch information. Affected products include: Wpdevart Countdown And Countup\, Woocommerce Sales Timer.